Placenta Previa Clinical Trial
Official title:
The Effect of Placenta Previa on Fetal Weight and Feto-maternal Blood Flow
Verified date | November 2017 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Placenta previa is a placenta that implants at lower uterine segment, it occurs in about
0.3-0.5% of pregnancies at term. It is a significant risk for development of maternal
morbidity, as well as maternal mortality secondary to maternal hemorrhage . Also, this
abnormal placenta has a negative concern about fetal well being due to prematurity and
perinatal mortality, in addition to its undesirable effect on fetal growth. Several factors
may be behind of the effect of placenta previa on fetal growth. Firstly, the blood supply to
the lower uterine segment is less than at the upper segment apparently resulting in less
feto-placental blood perfusion . Secondly, recurrent bleeding attacks from placental previa
may affect fetal oxygenation and fetal growth.
In spite of above evidences; many studies in literature denied the relation between placenta
previa and fetal growth and concluded that the association between low birth weight and
placenta previa is mainly due to preterm delivery and to a lesser extent with fetal growth
restriction. However; the major drawback of all these studies is lacking of reporting the
effect of placenta previa of feto-maternal blood flow representing in studying of Doppler
blood flow in both uterine and umbilical artery in those patients. The uterine artery blood
flow is usually affected by the presence of placenta previa and placenta accreta which
reflected on feto-placental blood flow. So the uterine artery Doppler velocimetry is a useful
tool for predicting placenta accreta .
So in the light of above evidences; we aimed, in the current study, not only to investigate
the effect on placenta previa on fetal weight but also to walk around the effect of placenta
previa on the uterine and umbilical arteries blood flow in trial to explore this conflicting
issue. To our knowledge, no previous trial had studied this interesting subject before.
Status | Completed |
Enrollment | 200 |
Est. completion date | October 1, 2017 |
Est. primary completion date | August 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 35 Years |
Eligibility |
Inclusion Criteria: 1. Women who are sure of her pregnancy. 2. Women aged 20-35 years. 3. Women with BMI 18-22 kg/m2. 4. Estimated gestational age is ranging between 30- 32 weeks gestation. 5. Singleton pregnancy. 6. Placenta previa; either major or minor degrees as regard the cases. 7. Placenta previa with minimal vaginal bleeding or haven't any vaginal bleeding. 8. Women with normal Doppler indices in uterine and umbilical arteries at time of recruitment. 9. Women should be living in a nearby area to make follow-up and early transportation are reasonably possible. Exclusion Criteria: 1. Women aged < 20 and >35 years. 2. Smoker = 11 cigarettes/day. 3. Severe attack of bleeding requiring an immediate intervention. 4. Fetal heart rates instability or non reassuring. 5. Multiple gestations. 6. Previous Intrauterine growth restricted fetus. 7. Intrauterine fetal death or major fetal anomalies. 8. If associated with abruptio placentae. 9. Patients with known bleeding disorders or on anticoagulant therapy |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Estimated fetal wight (gram) | 4 weeks | ||
Secondary | The value of Doppler indices in uterine artery | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04518150 -
Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section
|
N/A | |
Recruiting |
NCT04518163 -
Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa
|
N/A | |
Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
Terminated |
NCT01996345 -
Vaginal Pessary Versus Expectant Management for Placenta Previa
|
N/A | |
Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
Completed |
NCT03431116 -
Low Implanted Second Trimester Placenta and Placenta Previa
|
N/A | |
Enrolling by invitation |
NCT05529381 -
Anxiety and Depressive Symptoms in Placenta Previa / Accreta
|
||
Completed |
NCT04264234 -
Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria
|
N/A | |
Completed |
NCT05340205 -
Blood Loss During Cesarean Delivery in Placenta Previa Patients
|
Phase 4 | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Completed |
NCT05283122 -
Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases
|
N/A | |
Withdrawn |
NCT01442207 -
Cerclage for Prevention on Preterm Birth in Women With Placenta Previa
|
Phase 3 | |
Not yet recruiting |
NCT03451136 -
Cervical Length in Cases of Placenta Previa
|
N/A | |
Completed |
NCT02966197 -
Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
|
N/A | |
Recruiting |
NCT02590484 -
The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta
|
N/A | |
Recruiting |
NCT05802251 -
Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
|
||
Completed |
NCT03542552 -
Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa
|
Phase 3 | |
Recruiting |
NCT03124472 -
Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa
|
N/A | |
Recruiting |
NCT03633175 -
Progesterone in Patients With Placenta Previa
|
Phase 2 | |
Not yet recruiting |
NCT03208842 -
Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar
|
N/A |